Dear Colleagues, dear Friends,

It is with a great pleasure that we welcome you to the 17th International Forum on Mood and Anxiety Disorders (IFMAD 2017) that will be taking place this year on December 14– 16th in  Madrid!

IFMAD has developed the reputation over many years of being the most interactive, stimulating and productive educational meeting in its field in Europe and since 2015 we are providing an even more comprehensive scientific and educational programme.

It is accredited for continuing medical education. In a friendly atmosphere difficult clinical challenges are dissected, discussed and reformulated with high ranking experts to achieve the best evidence based path to treatment in depression, anxiety and bipolar disorder. To avoid bias, our educational program is completely independent from pharmaceutical support.

IFMAD 2017 topics will include: Update on rapid acting antidepressants, Treatment adherence, Cognition in Mood Disorders, Update on treatment of Anxiety Disorders, Advances in treatment of resistant depression, Biomarkers for Mood Disorders, Long acting antipsychotics in Bipolar Disorder, Update on psychoneuroimmunology, Overlap of negative symptoms and depression, Anxiety Disorder spectrum, Brain gut interactions.

We look forward to seeing you all in Madrid for IFMAD 2017, to building strong professional contacts an expanding international network, to welcoming new participants and meeting our old friends, and discussing together the most important issues in this area of medicine!